Holdings
晟德大藥廠股份有限公司
As of Oct 31, 2026, 晟德大藥廠股份有限公司 reported 7 positions. Largest: Lumosa Therapeutics Co Ltd, BioGend Therapeutics Co., Ltd. and Medeon Biodesign, Inc. What it bought and sold, with each filing.
Holdings
- Positions
- 7
- Holdings as of
- Oct 31, 2026
- Last filed
- Nov 22, 2026
| Company | Shares | % of company | Change | As of |
|---|---|---|---|---|
| Lumosa Therapeutics Co Ltd TPEX:6535 | 57.9M | 34.5% | No change | Oct 31, 2026 |
| BioGend Therapeutics Co., Ltd. TPEX:6733 | 45.2M | 33.7% | No change | Oct 31, 2026 |
| Medeon Biodesign, Inc. TPEX:6499 | 21.5M | 22.2% | −2M | Oct 31, 2026 |
| Mycenax Biotech Inc. TPEX:4726 | 42.1M | 20.3% | No change | Oct 31, 2026 |
| Anya Biopharm, Inc. TPEX:7776 | 8.27M | 16.8% | No change | Oct 31, 2026 |
| Ever Supreme Bio Technology Co., Ltd. TPEX:6712 | 10.7M | 10.7% | −11,000 | Oct 31, 2026 |
| Ever Fortune.AI Co., Ltd. TPEX:6841 | 3.52M | 3.7% | No change | Oct 31, 2026 |
| Mycenax Biotech Inc. TPEX:4726 | No change | Nov 22, 2026 | ||
| Medeon Biodesign, Inc. TPEX:6499 | No change | Nov 22, 2026 | ||
| Lumosa Therapeutics Co Ltd TPEX:6535 | No change | Nov 22, 2026 | ||
| Ever Supreme Bio Technology Co., Ltd. TPEX:6712 | No change | Nov 22, 2026 | ||
| BioGend Therapeutics Co., Ltd. TPEX:6733 | No change | Nov 22, 2026 |